Blackrock, INC Schedule 13G passive stakes
NYSE
SCHEDULE 13G/A: BlackRock Increases Stake in Anika Therapeutics to 6.8%
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 6.8% beneficial ownership stake in Anika Therapeutics Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.8% Passive Stake in Elevance Health
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.8% beneficial ownership stake in Elevance Health, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 9.1% beneficial ownership stake in Arrow Electronics Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, disclosing its beneficial ownership of 8.8% of Bath & Body Works, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.6% Passive Stake in Boston Scientific Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.6% passive beneficial ownership stake in Boston Scientific Corp as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 16 to its Schedule 13G, reporting an 8.8% beneficial ownership stake in CMS Energy Corp as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reaffirming its passive beneficial ownership of 7.4% of Campbell's Co common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.9% Stake in Citizens Financial Group
BlackRock, Inc. has filed an updated Schedule 13G, revealing a beneficial ownership of 8.9% of Citizens Financial Group Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.8% Passive Stake in Otis Worldwide Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.8% beneficial ownership stake in Otis Worldwide Corp's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.0% Passive Stake in PTC Therapeutics, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, revealing a passive beneficial ownership of 8.0% in PTC Therapeutics, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 6 to Schedule 13G, reporting a 7.1% beneficial ownership stake in TrueCar Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.3% Passive Stake in Twist Bioscience Corp
BlackRock, Inc. has filed an amended Schedule 13G, revealing a passive beneficial ownership of 8.3% of Twist Bioscience Corp's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 9.2% beneficial ownership stake in UNUM GROUP's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reaffirming its beneficial ownership of 7.6% of VAXCYTE, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.5% Stake in Virgin Galactic Holdings
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 5.5% beneficial ownership stake in Virgin Galactic Holdings, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, reaffirming its passive beneficial ownership of 6.1% of Vital Farms, Inc.'s Common Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.9% Stake in Zeta Global Holdings Corp.
Investment giant BlackRock, Inc. has reported a 6.9% beneficial ownership stake in Zeta Global Holdings Corp. common stock as of March 31, 2025, held for ordinary course of business.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.6% beneficial ownership stake in Air Products and Chemicals Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant Passive Stake in Alector Inc., Discloses 6.2% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, reporting a 6.2% beneficial ownership stake in Alector Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 9.3% Passive Stake in Sandisk Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.3% beneficial ownership stake in Sandisk Corp's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, reporting a 7.1% passive beneficial ownership stake in SmartFinancial Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 15 to its Schedule 13G, disclosing a 7.6% beneficial ownership stake in Travelers Companies, Inc. common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 11 to its Schedule 13G, reporting a 7.5% beneficial ownership stake in Travere Therapeutics, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant 8.4% Stake in Veracyte, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reaffirming its beneficial ownership of 8.4% of Veracyte, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.3% Stake in Backblaze Class A Stock
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 5.3% beneficial ownership stake in Backblaze Inc.'s Class A common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a passive beneficial ownership of 8.0% of CTO Realty Growth, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 7.5% of General Motors Co.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Grand Canyon Education, Maintains Significant Passive Ownership
BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, disclosing a 9.1% beneficial ownership stake in Grand Canyon Education Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.2% Passive Stake in Ingersoll Rand Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.2% passive beneficial ownership stake in Ingersoll Rand Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.9% beneficial ownership stake in the iShares Core Total USD Bond Market ETF as of March 31, 2025.